ADAM17 and cancer: On the one hand, our group has reported that the trans interaction between ADAM17 on TEVs and integrin α5β1 on target cells is involved in the binding and uptake of cancer-derived EVs, supporting a role for ADAM17 on TEVs as an integrin ligand and adhesion molecule [48].